Thioacetamide-induced acute hepatic encephalopathy: central vs peripheral effect of Allicin
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Springer
Series Info
Metabolic Brain Disease;Volume 36, pages 1331–1340, (2021)
Scientific Journal Rankings
Orcid
Abstract
Hepatic encephalopathy (HE) is a debilitating and life-threatening disease. Results from acute or chronic liver failure and is characterized by abnormal cerebral and neurological alterations. This study aimed at investigating the effect of allicin, the major functional component in freshly crushed garlic extract, on thioacetamide (TAA)-induced HE in rats. Induction of HE by a single dose of TAA (300 mg/kg; I.P.) was associated with a marked elevation in the serum levels of alanine aminotransferase, aspartate aminotransferase, bilirubin, albumin, total protein, blood urea nitrogen and serum ammonia besides reduction in the serum level of albumin. Moreover, it was accompanied with an increase in the hepatic and brain levels of inflammatory mediators; TNF-α and IL-1β as well as elevation of the hepatic and brain levels of oxidative stress biomarkers; reduced glutathione and lipid peroxidation evidenced by malondialdeyde. Oral administration of allicin (50, 100 and 200 mg/kg; P.O.) for 6 days prior to TAA injection restored the serum liver function, hepatic and brain levels of inflammatory mediators as well as oxidative stress biomarkers in a dose-dependent manner. From our results, it can be concluded that allicin has a protective effect on TAA-induced HE in rats in a dose-dependent manner due to its powerful antioxidant and anti-inflammatory properties.
Description
SJR 2024
0.941
Q2
H-Index
83
Citation
Saleh, D. O., Mansour, D. F., & Fayez, A. M. (2021). Thioacetamide-induced acute hepatic encephalopathy: central vs peripheral effect of Allicin. Metabolic Brain Disease, 36(6), 1331–1340. https://doi.org/10.1007/s11011-021-00695-7
